Table 5.
Therapeutic significant properties of top five hit molecules.
| Ligand No. | CNS | QPlogPo/w | QPlogS | QPlogBB | QPPMDCK | Metab | QPlogKhsa |
| ZINC13144609 | −2 | 0.421 | −2.727 | −2.005 | 44.317 | 4 | −0.693 |
| ZINC01581128 | −2 | 0.689 | −1.188 | −1.896 | 1.152 | 9 | −0.232 |
| ZINC06062920 | −2 | 0.457 | −1.421 | −2.09 | 0.729 | 8 | −0.23 |
| ZINC03022586 | −2 | −1.301 | −2.892 | −3.745 | 1.987 | 2 | −1.097 |
| ZINC00134422 | −2 | −0.8 | −2.191 | −2.579 | 5.219 | 2 | −0.799 |
| Rangea | −2 to +2 | −2 to 6.5 | −6.5 to 0.5 | −3.0 to 1.2 | <25 p >500 g | 1–8 | −1.5 to 1.5 |
aRange: for 95% oral drugs.